Literature DB >> 24816045

Chronic pulmonary penicilliosis due to Penicillium marneffei: late presentation in a french traveler.

Anne De Monte1, Karine Risso, Anne-Cécile Normand, Guy Boyer, Coralie L'Ollivier, Pierre Marty, Martine Gari-Toussaint.   

Abstract

We report a case of pulmonary penicilliosis due to Penicillium marneffei in an immunocompetent French patient with chronic obstructive pulmonary disease, who had traveled in endemic countries several years before. The long interval between exposure and initial symptoms of infection, and relapse despite prolonged voriconazole treatment are unusual features.
© 2014 International Society of Travel Medicine.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24816045     DOI: 10.1111/jtm.12125

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  8 in total

Review 1.  Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen.

Authors:  Cunwei Cao; Liyan Xi; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2019-12       Impact factor: 2.574

2.  Fungemia caused by Penicillium marneffei in an immunocompetent patient with COPD: A unique case report.

Authors:  Xiaoming Yu; Xueding Cai; Xiaomei Xu; Lin Zhang; Xiaoying Huang; Liangxing Wang; Yanfan Chen
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

3.  T. marneffei infection complications in an HIV-negative patient with pre-existing pulmonary sarcoidosis: a rare case report.

Authors:  Xiaoming Yu; Keji Miao; Changsheng Zhou; Yuelin Cai; Xiaoying Huang; Yanfan Chen; Mayun Chen; Hui Cai; Lin Zhang
Journal:  BMC Infect Dis       Date:  2018-08-10       Impact factor: 3.090

4.  Talaromyces marneffei infection in a non-HIV non-endemic population.

Authors:  Miriams Teresita Castro-Lainez; Miguel Sierra-Hoffman; Juan LLompart-Zeno; Robin Adams; Alan Howell; Holly Hoffman-Roberts; Robert Fader; Alejandro C Arroliga; Chetan Jinadatha
Journal:  IDCases       Date:  2018-03-03

Review 5.  Talaromyces marneffei Infection: Virulence, Intracellular Lifestyle and Host Defense Mechanisms.

Authors:  Kritsada Pruksaphon; Joshua D Nosanchuk; Kavi Ratanabanangkoon; Sirida Youngchim
Journal:  J Fungi (Basel)       Date:  2022-02-19

6.  Comparison of Talaromyces marneffei Infection in Human Immunodeficiency Virus-positive and Human Immunodeficiency Virus-negative Patients from Fujian, China.

Authors:  Hong-Ru Li; Shao-Xi Cai; Yu-Sheng Chen; Mei-E Yu; Neng-Luan Xu; Bao-Song Xie; Ming Lin; Xin-Lan Hu
Journal:  Chin Med J (Engl)       Date:  2016-05-05       Impact factor: 2.628

Review 7.  Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients.

Authors:  Jasper F W Chan; Susanna K P Lau; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  Emerg Microbes Infect       Date:  2016-03-09       Impact factor: 7.163

Review 8.  Pulmonary Talaromycosis: A Window into the Immunopathogenesis of an Endemic Mycosis.

Authors:  Shanti Narayanasamy; John Dougherty; H Rogier van Doorn; Thuy Le
Journal:  Mycopathologia       Date:  2021-07-06       Impact factor: 2.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.